Edition:
India

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

4.41USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$4.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
104,790
52-wk High
$7.60
52-wk Low
$3.68

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 16 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7 6.24 8.40 4.65 12.87
Quarter Ending Dec-18 7 15.82 22.96 5.85 15.54
Year Ending Dec-18 7 33.14 40.66 20.50 51.25
Year Ending Dec-19 7 46.38 56.70 35.40 73.31
Earnings (per share)
Quarter Ending Sep-18 6 -0.16 -0.08 -0.22 -0.17
Quarter Ending Dec-18 6 0.00 0.20 -0.16 -0.04
Year Ending Dec-18 7 -0.52 -0.27 -0.76 -0.42
Year Ending Dec-19 7 -0.34 -0.17 -0.60 -0.13

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 5.28 4.04 1.23 23.39
Quarter Ending Dec-17 6.82 10.46 3.64 53.33
Quarter Ending Sep-17 6.47 6.16 0.31 4.75
Quarter Ending Jun-17 4.72 5.16 0.43 9.16
Quarter Ending Mar-17 2.88 3.80 0.91 31.59

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6.24 6.24 6.24 6.24 12.87
Quarter Ending Dec-18 15.82 15.82 15.82 15.82 15.54
Year Ending Dec-18 33.14 33.14 33.14 33.14 51.25
Year Ending Dec-19 46.38 46.38 46.38 47.35 73.31

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings